ANGLE plc: Angle PLC - Parsortix Demonstrates High Capture Rate of CTCs
ANGLE plc: Angle PLC - Parsortix Demonstrates High Capture Rate of CTCs Parsortix system demonstrates high capture rate of CTCs irrespective of biomarker status or phenotype GUILDFORD, SURREY / ACCESSWIRE / January 29, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce the publication of a five year programme of work undertaken by the CANCER-ID Consortium to establish the performance and technical capabilities of five circulating tumour cell (CTC) isolation platforms, in which key advantages of the Parsortix ® system were identified. The CA...